Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection)

Published:2020-12-11 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Vallejo Maite¹,Reyes Pedro PA¹,Martinez Garcia Mireya²,Gonzalez Garay Alejandro G³

Affiliation:

1. Instituto Nacional de Cardiología Ignacio Chávez; Juan Badiano No. 1. Col. Seccion XVI; Tlalpan Mexico

2. Sociomedical Research Unit; Instituto Nacional de Cardiologia, Ignacio Chavez; Mexico City Mexico

3. Methodology Research Unit; Instituto Nacional de Pediatría; Mexico City Mexico

Publisher

Wiley

Subject

Pharmacology (medical)

Reference94 articles.

1. A controlled comparative study using benznidazole, nifurtimox and placebo in chronic Chagas disease patients, in a field area with interrupted transmission: I. preliminary evaluation;Coura;Revista da Sociedade Brasileira de Medicina Tropical,1997

2. Randomized trial of benznidazole for chronic Chagas' cardiomyopathy;Morillo;New England Journal of Medicine,2015

3. Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole;Aguiar;Tropical Medicine & International Health,2012

4. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease;Alvarez;Transactions of the Royal Society of Tropical Medicine and Hygiene,2012

5. New scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: a pilot short-term follow-up study with adult patients;Álvarez;Antimicrobial Agents and Chemotherapy,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiprotozoal drugs: challenges and opportunities;Expert Opinion on Therapeutic Patents;2023-03-04

2. Direct evidence gap on fixed versus adjusted‐dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta‐analysis;Tropical Medicine & International Health;2022-12

3. Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas’ disease;Journal of Antimicrobial Chemotherapy;2022-09-29

4. Mini-exon gene reveals circulation of TcI Trypanosoma cruzi (Chagas, 1909) (Kinetoplastida, Trypanosomatidae) in bats and small mammals in an ecological reserve in southeastern Mexico;ZooKeys;2022-01-28

5. Health-Related Quality of Life Reported by Patients With Chagas Disease: A Systematic Review of Qualitative Evidence With GRADE Recommendations;Revista da Sociedade Brasileira de Medicina Tropical;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3